Goodo.
But really all a tad vague, it seems to me: no indication of timing, no detail of milestones or of the relationship with St. Vincent’s Institute of Medical Research (which to be fair is likely as solid a partner EchoIQ could wish for).
Still counting down - now 76 sleeps - to 5 August for news from the US Food and Drug Administration (FDA) on EchoSolv™ AS.
Ann: Echo IQ Commences New Heart Failure Clinical Study Using AI, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
-0.010(5.88%) |
Mkt cap ! $86.02M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.0¢ | $62.72K | 378.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 123232 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 46126 | 3 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| EIQ (ASX) Chart |